{
    "nctId": "NCT01941784",
    "briefTitle": "Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy",
    "officialTitle": "Taking Health Realization Into Valued Eating and Exercise (THRIVE): A Feasibility Study of an Intervention to Prevent Weight Gain for Breast Cancer Survivors During Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 28,
    "primaryOutcomeMeasure": "Feasibility of conducting the weight gain prevention intervention, measured as the percent of screened participants that are eligible and agree to participate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with newly-diagnosed breast cancer, stage I-IV who are within first two rounds of chemotherapy\n* 3.1.2 Women who are receiving, or scheduled to receive, one of the following classes of therapy in the adjuvant or neo-adjuvant setting: anthracyclines, taxanes, cyclophosphamide, or trastuzumab. Participants must be within their first two rounds of chemotherapy - Body mass index (BMI) \\> 20\n* Treating physician approval to participate in study\n* Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document\n\nExclusion Criteria:\n\n* Diagnosis of recurrent breast cancer\n* Women who are already participating in a formal or medically prescribed weight management program\n* Women who have already completed more than two rounds of chemotherapy\n* Women who are pregnant or nursing",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}